scispace - formally typeset
A

A. A. Khutornenko

Researcher at Moscow State University

Publications -  11
Citations -  391

A. A. Khutornenko is an academic researcher from Moscow State University. The author has contributed to research in topics: Apoptosis & Mesenchymal stem cell. The author has an hindex of 7, co-authored 9 publications receiving 309 citations.

Papers
More filters
Journal ArticleDOI

Pyrimidine biosynthesis links mitochondrial respiration to the p53 pathway

TL;DR: It is shown that a shutdown of mitochondrial respiration per se does not trigger p53 response, because inhibitors acting in the proximal and distal segments of the respiratory chain do not activate p53.
Journal ArticleDOI

Improving the Post-Stroke Therapeutic Potency of Mesenchymal Multipotent Stromal Cells by Cocultivation With Cortical Neurons: The Role of Crosstalk Between Cells

TL;DR: It is concluded that the exchange by cellular compartments between neural and stem cells improves MMSCs' protective abilities for better rehabilitation after stroke.
Journal ArticleDOI

The Role of Dihydroorotate Dehydrogenase in Apoptosis Induction in Response to Inhibition of the Mitochondrial Respiratory Chain Complex III

TL;DR: It is shown that apoptosis in human colon carcinoma cells induced by the mitochondrial respiratory chain complex III inhibition can be prevented by supplementation with uridine or orotate rather than with dihydroorotate (a DHODH substrate), supported by the experiment showing that downregulation ofDHODH by RNA interference leads to accumulation of the p53 tumor suppressor and to apoptotic cell death.
Journal ArticleDOI

A sustained deficiency of mitochondrial respiratory complex III induces an apoptotic cell death through the p53-mediated inhibition of pro-survival activities of the Activating Transcription Factor 4

TL;DR: It is concluded that a downregulation of mitochondrial ETC generally induces adaptive pro-survival responses, which are specifically abrogated by the suicidal p53 response triggered by the genetic risks of the pyrimidine nucleotide deficiency.